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Abstract
Down syndrome remains the most common chromosomal abnormality in live-born 
infants in the world today. The association between Down syndrome and congenital 
heart disease (CHD) is well known, and it is widely recognized that CHD contributes sig-
nificantly to the morbidity of children with Down syndrome. The reported incidence of 
CHD in Down syndrome patients is between 40 and 60%. The most commonly described 
defect is complete atrioventricular septal defect (AVSD), which comprises 30–40% of all 
cardiac defects. Complex genetic factors are involved. Routine cardiac screening of all 
newborn babies with Down syndrome is recommended. Expert groups suggest that the 
cardiac status of all children with Down syndrome should be established by 6 weeks of 
age to permit appropriate and timely treatment avoiding the establishment of irrevers-
ible pulmonary vascular disease that would make corrective surgery impossible.
Keywords: Down syndrome, congenital heart disease, screening, AVSD, pulmonary 
hypertension
1. Introduction
Down syndrome remains the most common chromosomal abnormality in live-born infants in the 
world today [1]. The association between Down syndrome and congenital heart disease (CHD) 
is well known. It is widely recognized that CHD contributes significantly to the morbidity and 
mortality of children with Down syndrome. Despite this there continues to be reports of children 
with Down syndrome who present with serious CHD too late for the best chance of a good car-
diac outcome [2]. Early recognition of lesions is pivotal to obtain the best possible outcome, and 
education is still needed. In this chapter, we discuss the incidence and main types of CHD occur-
ring in the setting of Down syndrome. We focus mainly on atrioventricular septal defect (AVSD), 
which accounts for 30–40% of all cardiac defects in Down syndrome patients. We review genetic 
consideration and also discuss the principles of surveillance for cardiac disease in this population.
© 2018 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Prevalence and genetics
Prevalence of Down syndrome is estimated to be around 1–2 per 1000 live births [1]. The 
reported incidence of CHD in Down syndrome patients is between 40 and 60% [1–3]. The 
most commonly described defect is complete AVSD which comprises 30–40% of all cardiac 
defects. The types of CHD described in Down syndrome do seem to follow a fixed pattern; 
there are high numbers of septal defects in general; tetralogy of Fallot is described, but there 
are lower rates of other conotruncal defects like transposition or conditions such as coarcta-
tion [4]. Prevalence of individual lesions is given later in Table 1.
Obviously the triplication of chromosome 21 suggests that genes located in this area are likely 
to play an important role in the development of CHD. However the fact that Down syndrome 
is not invariably accompanied by CHD implies that more complex genetic factors are involved. 
No single gene candidate has been identified yet [1]. Recent research implicates Hsa21-encoded 
genes in the development of CHD [5]. Genes for several matrix-related proteins COL-α1 and 
COL-α2 and Down syndrome cell adhesion molecule (DSCM) are located in chromosome 21. 
Overexpression of these genes for collagen matrix-related proteins has been associated with 
development of AVSD [4]. However not all AVSDs are associated with trisomy 21. Other genes 
not located on chromosome 21 and environmental factors may play a role [1, 5].
Mutations in the cell adhesion molecule cysteine-rich epidermal growth factor-like domain 
(CRELD) 1 on chromosome 3 have also been implicated in the genetics of CHD in Down 
syndrome and correspond to one of the specific genetic loci identified for AVSD [6]. This 
molecule is thought to be essential to the process of cellular adhesion and formation of the 
endocardial cushions. Overexpression of the junction adhesion molecule (JAM) 2 has also 
been shown to potentiate CHD in mice that already have CRELD1 mutation [7]. Undoubtedly 
the genetic influence of chromosome 21 on CHD is complex and yet to be fully understood.
There is evidence to suggest that sex and ethnic differences do exist in the incidence of CHD in 
Down syndrome, particularly among those with AVSD. There is a predominance of female infants 
Percentage of Down syndrome patients affected by study
Tubman et al. [3] Frid et al. [17] Freeman et al. [8] Stoll et al. [18]
AVSD 38% 47% 39% 30%
VSD 15% 33% 43% 22%
ASD 21% 8% 42% 25%
Tetralogy of Fallot — 2% 6% 3%
Coarctation — 1% — 5%
TGA — — — —
Patent ductus 18% 9% — 5%
Table 1. Percentage of patients with Down syndrome affected by congenital heart disease by defect.
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affected by AVSD and VSD [8]. Black infants with Down syndrome appear to have around twice 
the risk of AVSD as white infants, whereas Hispanic infants have a much smaller risk than white 
infants [8]. The type of lesion is thought to vary according to geographical area. For example, 
in Brazil the most frequently described defect is an atrial septal defect (ASD) [9, 10]. In Asia the 
most common lesion is a ventricular septal defect (VSD) [11]. A group in Sweden reports AVSD 
as the most frequent lesion like other Western European countries and the USA. Interestingly 
they also note a decreasing frequency of complex CHD in Down syndrome; such a trend could 
be explained by selective termination of fetuses with Down syndrome in some areas [12].
3. Surveillance and screening
The American Academy of Pediatrics recommends routine cardiac screening of all newborn 
babies with Down syndrome [13]. This statement is echoed by the Down Syndrome Medical 
Interest group (DSMIG UK). They recommend that the cardiac status of all children with Down 
syndrome should be established by 6 weeks of age [2]. Age at evaluation is an important factor 
for reduction in morbidity and mortality rates. Failure to recognize cardiac defects early in life 
can have serious consequences including establishment of irreversible pulmonary vascular dis-
ease that makes corrective surgery impossible [3]. The fact that children still occasionally present 
to pediatric cardiology clinics in this fashion indicates that the importance of early detection is 
not fully acknowledged, even in the present era [9, 14]. Neonatal and infant mortality in patients 
with Down syndrome remains higher than in the general population, primarily due to CHD [1].
Clinical examination alone remains insufficient to reliably diagnose CHD in Down syndrome 
with only around 40% of newborns having a cardiovascular abnormality detected based 
solely on clinical findings [3, 15]. An ECG is likely to be abnormal, particularly in the setting 
of AVSD, and an abnormal ECG has been shown to have a high positive predictive value for 
congenital heart disease [3]. Taken together clinical examination and ECG are more powerful 
than either individually [3].
Echocardiography is undoubtedly the most effective single diagnostic test however even 
it is not 100% effective in identifying lesions in the neonatal period. Authors acknowledge 
that echocardiography should only be carried out by pediatric cardiologists or experienced 
pediatricians with special interest in cardiology that have access to the necessary equipment 
and technical skills [3, 15]. There should be a low threshold for repeating the investigation if 
symptoms or signs of cardiac disease present at any age, even with a history of previously 
normal echocardiogram [2]. Diagnosis of purely physiological shunts such a PFO or PDA 
may cause unnecessary worry for some parents.
The DSMIG suggest that all babies with a diagnosis of Down syndrome should have a thor-
ough clinical examination and ECG performed shortly after diagnosis and that the urgency 
of their assessment by a pediatric cardiologist should be determined on the basis of these 
investigations, such that those with abnormal signs or abnormal ECG be seen within 2 weeks 
for echocardiogram and those felt to be at lower risk based on the initial tests be seen within 
6 weeks from birth [2].
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Figure 1. The arrangement of the common atrioventricular valve leaflets in complete AVSD.
4. Common cardiac defects occurring in Down syndrome
The major types of congenital heart defect occurring in Down syndrome are listed in Table 1. 
As noted earlier the most common defect is AVSD, which can affect up to 40% of patients 
[1]. Conversely around 80% of all AVSDs occur in children with Down syndrome [16]. We 
describe the morphology and pathophysiology of some of the major types of CHD associated 
with Down syndrome.
AVSD, atrioventricular septal defect; VSD, ventricular septal defect; ASD, atrial septal defect; 
TGA, transposition of the great arteries.
4.1. Atrioventricular septal defect (AVSD)
The term AVSD covers a broad spectrum of CHD characterized by a common atrioventricular 
junction with coexisting deficiency in the atrioventricular septum. AVSD comprises around 
7% of all CHD and is also referred to as an endocardial cushion defect [19].
The common atrioventricular junction is usually ovoid with unwedging of the left ventricular 
outflow tract from the usual position between mitral and tricuspid valves. Instead of separate 
inlet valves, the AV junction is guarded by a common valve, which often is comprised of 
five leaflets, two of which are bridging leaflets across the crest of the interventricular septum 
(Figure 1). These are termed superior and inferior bridging leaflets, respectively. There is also 
a left lateral (mural) leaflet, right anterosuperior leaflet, and a right inferior leaflet [16, 19].
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The Rastelli classification from 1966 divides complete AVSD into three subgroups on the basis 
of the anatomy of the superior bridging leaflet and its chordal attachments (Figure 2). In 
Rastelli type A, the superior bridging leaflet is divided at the level of the ventricular septum; 
in Rastelli type B, the division of the superior bridging leaflet occurs to a right ventricular pap-
illary muscle; and in Rastelli type C, the superior bridging leaflet is undivided or free floating. 
Rastelli type C is the most common arrangement found in Down syndrome [20].
In complete AVSD, shunting occurs at both atrial and ventricular levels; however, attach-
ment of the bridging leaflets to the crest of ventricular septum results in an exclusively atrial 
shunt through a primum ASD, also called a partial AVSD (see later), whereas attachment of 
the bridging leaflet to the atrial septum results in exclusively ventricular shunting (Figure 3).
Other congenital heart defects commonly associated with AVSD include left ventricular out-
flow tract obstruction especially in the setting of a Rastelli type A superior bridging leaflet as 
there is extreme unwedging of the aorta from its usual position and consequent elongation 
of the outflow tract. Ventricular hypoplasia and atrial isomerism are also described although 
infrequently with Down syndrome. Tetralogy of Fallot is the most commonly observed asso-
ciation and is seen in up to 6.7% cases of AVSD [20]. There is a high incidence of associated 
other extra cardiac abnormalities. One study of 87 patients with Tetralogy and AVSD reported 
that 67% of these patients had Down syndrome [21].
Clinical presentation relates to the morphology of the AVSD and any associated defects. If the 
ventricular component is large, left to right shunting occurs after the first few weeks of life as the 
pulmonary vascular resistance falls, and the infant will develop signs of congestive heart failure. 
Figure 2. Rastelli classification. Type a (top): The superior bridging leaflet is divided at the ventricular septum. Type B 
(middle): The division occurs to a right ventricular papillary muscle. Type C (bottom): The superior bridging leaflet is 
undivided.
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If there is associated significant AV valve regurgitation, ventricular imbalance or coarctation signs 
of cardiac failure will occur much earlier [16, 20]. There is a small subgroup of patients with 
complete AVSD who do not develop signs of cardiac failure despite a significant ventricular com-
ponent. In these individuals there is persistent elevation of pulmonary vascular resistance [20].
In the present era, medical treatment is aimed at optimizing the patient’s condition to get to 
corrective surgery. This includes maximizing fluids and calorie intake, often with supple-
mental nasogastric tube feeding to promote good nutrition. Symptomatic management of 
congestive heart failure is with diuretics and ACE inhibitor therapy. The aim of surgery is to 
completely close the septal defects and repair the AV valve. Today surgery is offered to all 
Down syndrome patients with CHD although this was not always the case. Surgical results 
are good, and there is believed to be no extra risk from the concomitant presence of Down 
syndrome [22, 23]. Surgical repair is aimed in the first few months of life and certainly before 
6 months old as irreversible pulmonary vascular disease is more likely to develop quickly 
in patients with Down syndrome and AVSD. Surgery is usually successful with low opera-
tive mortality. The most recent statistics from National Institute for Cardiovascular Outcomes 
Research (NICOR) suggest that survival following complete AVSD repair is 99.5% at 30 days 
post-op and 91.9% at 1 year [24]. Without corrective surgery many patients with complete 
AVSD will die in infancy, with only 4% surviving beyond 5 years old [25]. Those who survive 
will develop pulmonary vascular disease and eventual reversal of the systemic to pulmonary 
shunt with accompanying cyanosis or Eisenmenger’s syndrome.
Postoperative complications following surgical repair of complete AVSD are listed in Table 2. 
Those seen most commonly are left ventricular outflow tract obstruction and left AV valve 
regurgitation. Left AV valve regurgitation forms the most common reason for reoperation in 
A B
Exclusively ventricular shuntingExclusively atrial shuntingAtrial and ventricular shunting
C
Figure 3. Resultant shunting in complete AVSD depends on the arrangement of the bridging leaflets with the atrial and 
ventricular septum.  (A) atrial and ventricular shunting, (B) exclusively atrial shunting, (C) exclusively ventricular shunting. 
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most surgical series [26]. Interestingly, the morphology of the AV valve most associated with 
Down syndrome, Rastelli type C, may actually be more favorable for surgical repair as there 
is often extensive bridging of both superior and inferior bridging leaflets resulting in less left 
AV valve regurgitation. Surgical series demonstrate that patients with Down syndrome expe-
rience greater freedom from reoperation for left AV valve regurgitation than those without 
Down syndrome [27].
4.2. Primum atrial septal defect/partial AVSD
In an isolated primum ASD or partial AVSD, the AV junction is a common structure; however, 
there are separate right and left AV valve orifices as a band of valve tissue joins the superior 
and inferior bridging leaflets. The AV valves appear at the same level, and there may be regur-
gitation through the zone of opposition or “cleft” in the left AV valve (Figure 4). Timing of 
surgery in this case is less crucial especially if there is minimal AV valve regurgitation. Repair 
is often carried out in late infancy or early childhood. Isolated primum ASD unrepaired car-
ries 50% mortality before the age of 20 years [16]. Surgical results are good, and 30-day and 
1-year survival are 98.8 and 98.7%, respectively [24]. Long-term complications are similar to 
those described following AVSD repair with the most common reason for reoperation being 
left AV valve regurgitation followed by left ventricular outflow tract obstruction [26].
4.3. Tetralogy of Fallot
Tetralogy of Fallot is a conotruncal defect caused by the anterior and cephalad deviation of the 
infundibular septum, which leads to the development of the four characteristic components: 
ventricular septal defect, overriding aorta, right ventricular outflow tract obstruction, and 
right ventricular hypertrophy (Figure 5). Tetralogy of Fallot occurs in around 6% of patients 
with Down syndrome and is the most common cyanotic heart defect to present in this patient 
group. Conversely around 8% of patients with Tetralogy of Fallot have Down syndrome, 
although this is slightly higher in fetal series [28].
• Left atrioventricular valve regurgitation
• Left ventricular outflow tract obstruction
• Late-onset complete heart block
• Pulmonary vascular disease
• Atrial or ventricular rhythm problems
• Left atrioventricular valve stenosis
• Right atrioventricular valve stenosis or regurgitation
• Residual ventricular septal defect
• Aortic incompetence
Table 2. Long-term complications following repair of complete AVSD [16, 19].
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Clinical presentation of tetralogy of Fallot depends very much on the degree of outflow 
tract obstruction present. Patients may present with profound central cyanosis in the neo-
natal period if the obstruction is severe and may actually be duct dependent, i.e., there is 
insufficient pulmonary blood flow once the ductus arteriosus closes. These patients require 
palliation with a Blalock-Taussig shunt or ductal stent to secure pulmonary blood flow and 
permit growth for corrective surgery. If there is little outflow tract obstruction, the patient 
may exhibit signs and symptoms of congestive cardiac failure as there will be a large left to 
right shunt through the VSD; in this case there will be little or no cyanosis.
Most commonly, patients fall somewhere in between and have a degree of outflow tract 
obstruction often presenting with an ejection systolic murmur and some cyanosis [28]. The 
degree of cyanosis is often variable, and patients may have cyanotic spells, which result from 
an acute increase in right to left shunting due to spasm of the muscular infundibular region. 
Patients with cyanosis or frequent spells that cannot be managed with beta blocker therapy 
may require a RVOT stent. Corrective surgery is performed at around 6–8 months of age. 
Outcomes are good, and survival following tetralogy repair is 99.7% at 30 days and 97.8% at 
1 year [24]. Common long-term complications are listed in Table 3.
The relief of right ventricular outflow tract obstruction during tetralogy of Fallot repair results 
in chronic pulmonary regurgitation, which subsequently leads to right ventricular dilatation 
Zone of apposition
Connecting tongue
Separate right and left valvar orifices
Figure 4. Arrangement of the common atrioventricular valve leaflets in primum ASD.
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necessitating interventions. The most frequent reason for reoperation in this patient group is to 
replace the pulmonary valve either surgically or percutaneously [28, 29]. There is evidence to 
suggest that patients with Down syndrome who have undergone tetralogy of Fallot repair come 
to pulmonary valve replacement more frequently than patients without Down syndrome. This 
is felt to be due to the presence of pulmonary arterial hypertension, also common in Down syn-
drome, which contributes to more severe pulmonary regurgitation and earlier RV dilatation [30].
Figure 5. Diagrammatic representation of tetralogy of Fallot.
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4.4. Ventricular septal defect (VSD)
A ventricular septal defect is defined as a hole between the right and left ventricles. In most 
series it is the second most common form of CHD described in Down syndrome (Table 1). 
VSDs are generally classified depending on what portion of the ventricular septum they span, 
illustrated in Figure 6. In Down syndrome VSDs often occur in the inlet septum [31]. In a large 
series of patients with Down syndrome, inlet VSD was one of the most frequently reported 
subtypes. Muscular and subarterial VSDs were not described [32]. Inlet VSD is associated 
with abnormalities of the left AV valve with straddling chordal and papillary muscle attach-
ments [31]. In the setting of Down syndrome, these defects likely form part of the AVSD 
complex described earlier [32].
Figure 6. Diagrammatic representation of possible VSD locations on standard echo views.  (A) long axis view, (B) short axis 
view at aortic valve level, (C) short axis view through ventricles, (D) four chamber view, (E) left ventricular outflow tract view.
• Pulmonary regurgitation
• Right ventricular dilatation and dysfunction
• Residual right ventricular outflow tract obstruction
• Branch pulmonary stenosis
• Rhythm problems
• Aortic incompetence
• Aortic root dilatation
Table 3. Long-term complications following tetralogy of Fallot repair [29].
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Similarly to AVSD, a VSD results in a left to right shunt with extra pulmonary blood flow, 
the magnitude of which depends on both the size of the defect and the patient’s pulmonary 
vascular resistance. Hemodynamically significant defects are repaired before 6 months of age. 
Like AVSD uncorrected lesions will lead to the development of pulmonary vascular disease 
and Eisenmenger’s syndrome [31].
4.5. Other lesions
From late adolescence there is evidence of an increased incidence of asymptomatic mitral 
valve prolapse (MVP) and aortic incompetence in children with Down syndrome. These are 
often asymptomatic; however, the MVP in particular can progress to symptomatic mitral 
regurgitation, and it is recommended that auscultation continues to be part of surveillance for 
individuals with Down syndrome in adult life [2].
5. Pulmonary hypertension in Down syndrome
Patients with Down syndrome are considered to be at higher risk of pulmonary arterial 
hypertension both with and without CHD. This is likely to be multifactorial, but the high 
incidence of CHD and airway problems undoubtedly plays a pivotal role in its development 
[33]. Down syndrome patients have a high incidence of gastroesophageal reflux with micro-
aspiration, recurrent respiratory infections, and sleep apnea. They may experience chronic 
hypoxia from upper airway obstruction in the form of tracheobronchomalacia, stenosis, or 
subglottic compromise [33]. There is a high prevalence of persistent pulmonary hypertension 
of the newborn in infants with Down syndrome, and as discussed earlier, there is a small 
subset of Down syndrome CHD patients who continue to have elevated pulmonary vascular 
resistance beyond the newborn period [16].
In the setting of a significant left to right shunt, intrinsic lung abnormalities such as abnor-
mal pulmonary arterioles, a smaller number of alveoli, and impaired endothelial function 
contribute to the development of pulmonary arterial hypertension in association with CHD 
[34]. As observed earlier, timely corrective surgery will prevent irreversible lung damage and 
development of Eisenmenger’s syndrome. Despite this move to early surgery, there remain 
a significant number of Down syndrome patients with Eisenmenger’s syndrome among the 
adult congenital heart disease population. Some studies estimate that as many as 50% of the 
total population of Eisenmenger’s patients have Down syndrome; there is also evidence to 
suggest that this group receives significantly less therapy and is often under-managed [35].
6. Conclusions
Congenital heart disease is one of the most frequent associations with Down syndrome 
and remains a major cause of morbidity and mortality among patients. Over half of Down 
syndrome patients have CHD the most common form being complete AVSD. Ethnic and 
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geographical variations among lesions have been described. Early recognition of lesions is 
paramount to permit appropriate and timely treatment. To this end, cardiac screening should 
be undertaken in all newborn infants with Down syndrome.
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